Vidaza Injection, Powder, Lyophilized, For Solution
Product Images NDC 59572-102
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Vidaza (NDC 59572-102). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Celgene Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 01
The given text is a graph showing the proportion surviving in time (months) from randomization. It also includes Log-Rank p-value and HR (Hazard ratio) with their confidence intervals. The deaths in two different groups are also mentioned namely Aza (82 deaths) and CCf. The rest of the text is not readable.*
Principal Display Panel (100 mg Vial Label)
Vidaza (azacitidine for injection) is a sterile medication used for subcutaneous and intravenous administration. The single-use vial contains 100mg azacitidine and 100mg mannitol. This medicine should be used in accordance with the prescribing information for administration and dosage. Discard unused portions, and store in a controlled room environment with excursions permitted at 25-30°C (77-86°F).*
Principal Display Panel (100 mg Carton Label)
Principal Display Panel (100 mg Vial Label)
Description: This is a label of a medication called Pazacitidine. It is a single-use vial containing 100 mg Pazacitidine and 100mg Mannil. The medication is meant for subcutaneous and intravenous use only. The label also includes information on dosing, administration, storage, and safe disposal of unused medication.*
Principal Display Panel (100 mg Carton Label)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.